Rezultati - Vivek Abraham

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Marizomib activity as a single agent in malignant gliomas: ability to cross the blood-brain barrier

    Marizomib activity as a single agent in malignant gliomas: ability to cross the blood-brain barrier od Kaijun Di, G. Kenneth Lloyd, Vivek Abraham, Ann MacLaren, Francis Burrows, Annick Desjardins, Mohit Trikha, Daniela A. Bota

    Izdano 2015
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  2. 2
    The Bcl-2/Bcl-XL/Bcl-w Inhibitor, Navitoclax, Enhances the Activity of Chemotherapeutic Agents <i>In Vitro</i> and <i>In Vivo</i>

    The Bcl-2/Bcl-XL/Bcl-w Inhibitor, Navitoclax, Enhances the Activity of Chemotherapeutic Agents <i>In Vitro</i> and <i>In Vivo</i> od Jun Chen, Sha Jin, Vivek Abraham, Xiaoli Huang, Bernard A. Liu, Michael J. Mitten, Paul Nimmer, Xiaoyu Lin, Morey L. Smith, Yu Shen, Alexander R. Shoemaker, Stephen K. Tahir, Haichao Zhang, Scott Ackler, Saul H. Rosenberg, Heather Maecker, Deepak Sampath, Joel D. Leverson, Chris Tse, Steven W. Elmore

    Izdano 2011
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:

Iskalna orodja: